跳至主要内容
临床试验/JPRN-UMIN000027280
JPRN-UMIN000027280招募中3 期

Japanese trial -A Global Study To Evaluate The Potential Benefit of Adjuvant Chemotherapy for Small Bowel Adenocarcinoma (JCOG1502C, J-BALLAD) - Japanese trial -A Global Study To Evaluate The Potential Benefit of Adjuvant Chemotherapy for Small Bowel Adenocarcinoma (JCOG1502C, J-BALLAD)

Japan Clinical Oncology Group (JCOG)0 个研究点目标入组 150 人开始时间: 2017年5月9日最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
发起方
入组人数
150

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
16years-old 至 74years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) Synchronous or metachronous (within 5 years) malignancies 2) Active infection requiring systemic therapy. 3) Body temperature of 38 degrees Celsius or higher. 4) Female during pregnancy, within 28 days of postparturition, or during lactation. 5) Severe psychological disease. 6) Continuous systemic corticosteroid or immunosuppressant treatment. 7) Inflammatory bowel disease (ex. Crohn disease, ulcerative colitis) or malabsorption (ex. Celiac disease) requiring therapy. 8) Uncontrollable diabetes mellitus 9) Uncontrollable hypertension 10) Unstable angina pectoris, or history of myocardial infarction within 6 months. 11) Positive HIV antibody. 12) Interstitial pneumonia, pulmonary fibrosis, or severe emphysema based on chest CT.

研究者

发起方
Japan Clinical Oncology Group (JCOG)

相似试验